Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2017 1
2021 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Characteristics of myasthenia gravis in elderly patients: a retrospective study.
Li Y, Dong X, Li Z, Peng Y, Jin W, Zhou R, Jiang F, Xu L, Luo Z, Yang H. Li Y, et al. Neurol Sci. 2022 Apr;43(4):2775-2783. doi: 10.1007/s10072-021-05599-z. Epub 2021 Oct 22. Neurol Sci. 2022. PMID: 34677704
Anti-acetylcholine receptor antibody was the dominant subtype, whereas anti-muscle-specific tyrosine kinase antibody was rare and detected only in non-elderly patients. ...
Anti-acetylcholine receptor antibody was the dominant subtype, whereas anti-muscle-specific tyrosine kinase
Prompt Response to Prednisone Predicts Benign Course in MuSK-MG.
Gungor-Tuncer O, Yilmaz V, Toker A, Saruhan-Direskeneli G, Gulsen-Parman Y, Oflazer-Serdaroglu P, Deymeer F. Gungor-Tuncer O, et al. Eur Neurol. 2017;78(3-4):137-142. doi: 10.1159/000479228. Epub 2017 Jul 28. Eur Neurol. 2017. PMID: 28768265
Clinical and immunological differences between early and late-onset myasthenia gravis in Japan.
Suzuki S, Utsugisawa K, Nagane Y, Satoh T, Kuwana M, Suzuki N. Suzuki S, et al. J Neuroimmunol. 2011 Jan;230(1-2):148-52. doi: 10.1016/j.jneuroim.2010.10.023. Epub 2010 Nov 12. J Neuroimmunol. 2011. PMID: 21074862
The ocular form was more frequent in late-onset compared to early-onset group. Seropositivity of anti-muscle-specific tyrosine kinase antibody was 2-3% in acetylcholine receptor-seronegative patients. ...
The ocular form was more frequent in late-onset compared to early-onset group. Seropositivity of anti-muscle-specific